Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institute of Neurological Disorders and Stroke (NINDS) plans to issue a Notice of Funding Opportunity aimed at supporting research focused on novel therapeutic interventions and testing strategies for neurological disorders, with an emphasis on epilepsy. The initiative seeks applications that explore various modalities to treat, modify, and prevent the development of epilepsy through innovative approaches. Researchers are encouraged to develop and validate human-focused testing strategies, as well as contribute expertise in preclinical therapy testing and model development. This funding opportunity does not allow clinical trials under the U24 mechanism and emphasizes preclinical and translational research efforts. The solicitation encourages multidisciplinary approaches to advance therapeutic development for neurological conditions, particularly epilepsy. Interested investigators are advised to contact Brian Klein, PhD, at the National Institutes of Health for further information. The announcement was posted in late September 2025 by the Department of Health and Human Services.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Institute of Neurological Disorders and Stroke (NINDS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to investigate novel therapeutic interventions and testing strategies for neurological disorders including to treat, modify, and prevent epilepsy. This research should include various intervention modalities and testing strategies. Investigators should consider testing strategies for the development and validation of human-focused testing approaches. Investigators with expertise and insights into preclinical therapy testing and model development are encouraged to consider applying for this new NOFO.
